Structure | Chemical Name | CAS | MF |
|
1R-cis-Permethrinic acid
|
55667-40-8
|
C8H10Cl2O2
|
|
(8R,15bS,16S)-4,11,16-Trihydroxy-6,9-dimethyl-7H-8,15b-methano-1H,3H,12H-benzo[de]cyclohepta[1,2-g:3,4,5-d'e']bis[2]benzopyran-3,7,12,15(8H)-tetrone
|
7545-84-8
|
C26H16O9
|
|
1R-cis,trans-chrysanthemic acid
|
|
|
|
(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester
|
149809-43-8
|
C21H21F2N3O4S
|
|
4R-Cis-Tert-Butyl-6-CyanoMethyl-2,2-Dimethyl-1,3-Dioxane-4-Acetate
|
|
C14H23NO4
|
|
(1R-cis)-1-(2,2,6-trimethylcyclohexyl)ethanone
|
52612-42-7
|
C11H20O
|
|
(5R-cis)-Toluene-4-sulfonic acid-5-(2,4-difluoro-phenyl)-5-[1,2,4]triazol-1-ylmethyl-tetrahydro-furan-3-ylmethyl ester
|
|
C21H21F2N3O4S
|
|
(2R-cis)-tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-pyran
|
|
C10H18O
|
|
RbsT protein
|
|
|
|
(R)-Citric acid 1-isopropyl ester
|
|
C9H14O7
|
|
(R)-(-)-CITRAMALIC ACID
|
6236-10-8
|
C5H8O5
|
|
(R)-(-)-CITRONELLYL BROMIDE
|
10340-84-8
|
C10H19Br
|
|
(R)-citramalate synthase
|
|
|
|
(R)-(+)-CITRONELLIC ACID
|
18951-85-4
|
C10H18O2
|
|
RbtK protein
|
|
|
|
RCK4 channel
|
|
|
|
R-DACH (1R,2R)-DIAMINOCYCLOHEXANE
|
|
|
|
RBTN1 protein
|
|
|
|
RBTN2 protein
|
|
|
|
R-BUFFER CG
|
|
|
|
R-BUFFER UG
|
|
|
|
R-BUFFER AG
|
|
|
|
R-BUFFER C
|
|
|
|
R-BUFFER A
|
|
|
|
R-BUFFER U
|
|
|
|
R-BUFFER B
|
|
|
|
R-BUFFER BG
|
|
|
|
RBT1 protein
|
|
|
|
(R)-Bufuralol Hydrochloride
|
57704-11-7
|
C16H24ClNO2
|
|
(4R)-3,5β,6bβ-Trimethyl-4,4aα,5,5aα,6,6aα,6b,7-octahydrocycloprop[2,3]indeno[5,6-b]furan-4α-ol
|
1618-84-4
|
C15H20O2
|
|
(4R)-3,5β,6bβ-Trimethyl-4,4aα,5,5aα,6,6aα,6b,7-octahydrocycloprop[2,3]indeno[5,6-b]furan-4α-ol acetate
|
59246-85-4
|
C17H22O3
|
|
R: CL
|
128092-74-0
|
C19H13ClF2
|
|
rbTrypsin
|
|
|
|
(2R)-(-)-1,1-Bis(4-methoxyphenyl)-3-methyl-1,2-butanediamine
|
166764-19-8
|
C19H26N2O2
|
|
RbtT protein
|
|
|
|
rC-JUN
|
|
|
|
(R)-(-)-DBD-APY
|
143112-50-9
|
C12H17N5O3S
|
|
(24R)-5α-Dammara-20-ene-3β,24,25-triol
|
55050-69-6
|
C30H52O3
|
|
(20R)-Dammar-24-ene-3β,20-diol
|
14351-28-1
|
C30H52O2
|
|
(R)-Bunitrolol
|
46905-83-3
|
|
|
(R)-(-)-DBD-PY-NCS
|
163927-31-9
|
C13H15N5O3S2
|
|
rbVEGF
|
|
|
|
(R)-(+)-1-(4-DANSYLAMINOPHENYL)ETHYLAMINE
|
|
C20H23N3O2S
|
|
R2D5 antigen
|
|
|
|
(R)-(+)-BUPIVACAINE HCL
|
27262-45-9
|
C18H28N2O
|
|
(R)-(+)-Bupivacaine monohydrochloride
|
27262-46-0
|
C18H29ClN2O
|
|
(R)-Dapoxetine hydrochloride
|
|
|
|
(R)-Bupropion Hydrochloride
|
849797-12-2
|
C13H19Cl2NO
|
|
(R)-Bupropion D-Tartaric Acid Salt
|
|
C17H24ClNO7
|
|
(R)-Bupropion
|
|
C13H18ClNO
|
|
R-Bupranolol
|
61877-83-6
|
C14H22ClNO2
|
|
Rck1 protein kinase
|
|
|
|
RCK protein
|
172930-00-6
|
|
|
Rck2 protein kinase
|
|
|
|
(R)-Darifenacin HydrobroMide
|
1092800-15-1
|
C28H31BrN2O2
|
|
[R,(-)]-1,2-Butanediamine
|
|
C4H12N2
|
|
[R,(+)]-2-Butanesulfonic acid
|
|
C4H10O3S
|
|
(+)-1,1'-[(R)-Butane-1,2-diyl]bis(3-phenylthiourea)
|
|
C18H22N4S2
|
|
[R,(+)]-1,1,2-Butanetricarboxylic acid
|
|
C7H10O6
|
|
[R,(-)]-1,3-Butanediamine
|
|
C4H12N2
|
|
[R,(-)]-2-Butanethiol
|
52945-73-0
|
C4H10S
|
|
[R,(+)]-1,2,4-Butanetricarboxylic acid trisodium salt
|
|
C7H7Na3O6
|
|
[R,(+)]-1,2,4-Butanetricarboxylic acid
|
|
C7H10O6
|
|
[R,(+)]-2-Butanesulfonic acid sodium salt
|
|
C4H9NaO3S
|
|
[R,(+)]-1,2,4-Butanetricarboxylic acid trimethyl ester
|
|
C10H16O6
|
|
[R,(+)]-1,2,4-Butanetriol 1,4-bis(methanesulfonate)
|
|
C6H14O9S2
|
|
[R,(+)]-1,2,4-Butanetricarboxylic acid triethyl ester
|
|
C13H22O6
|
|
(R)-BUTAPROST
|
69685-22-9
|
C24H40O5
|
|
(R)-(-)-butane-1,3-diol
|
|
C4H10O2
|
|
(2R)-Butanedioic acid, 2-(1-ethoxy)ethoxy-, diethyl ester
|
|
C12H22O6
|
|
Mitratapide
|
179602-65-4
|
C36H41ClN8O4S
|
|
(R)-1,3-BUTANEDIOL EE 99+%
|
|
C6H14O
|
|
(R)-BUTADIENEMONOXIDE
|
|
C4H5O-
|
|
R-BUTADIENEMONOEPOXIDE
|
|
C4H6O
|
|
(R)-1,2-Butanediol
|
40348-66-1
|
C4H10O2
|
|
(R)-(+)-1,2,4-BUTANETRIOL
|
70005-88-8
|
C4H10O3
|
|
(R)-BUTAPROST
|
69648-38-0
|
C24H40O5
|
|
(R)-(-)-1,3-Butanediol
|
6290-03-5
|
C4H10O2
|
|
(R)-1,2,4-BUTANETRIOL TRIMESYLATE
|
203515-83-7
|
C7H16O9S3
|
|
R-(-)-2-Butanol
|
14898-79-4
|
C4H10O
|
|
(R)-But-3-en-2-amine
|
63731-07-7
|
C4H9N
|
|
(R)- 2-(3'-butenyl) glycine
|
103067-78-3
|
C6H11NO2
|
|
(R)- 2-(3'-butenyl) alanine
|
1932326-29-8
|
C7H13NO2
|
|
(R)-5-BUT-3-ENYL-PYRROLIDIN-2-ONE
|
|
C8H13NO
|
|
(R)-3-BUTENE-1,2-DIOL
|
86106-09-4
|
C4H8O2
|
|
(R)-3-BUTEN-2-OL)
|
33447-72-2
|
C4H8O
|
|
(1R)-1-(4-BUTOXYPHENYL)BUTYLAMINE
|
|
C14H23NO
|
|
(1R)(4-BUTOXY-3-METHOXYPHENYL)CYCLOPROPYLMETHYLAMINE
|
|
C15H23NO2
|
|
(1R)-1-(4-BUTOXY-3-ETHOXYPHENYL)BUTYLAMINE
|
|
C16H27NO2
|
|
(1R)-1-(4-BUTOXYPHENYL)PENTYLAMINE
|
|
C15H25NO
|
|
(1R)-1-(4-BUTOXY-3-METHOXYPHENYL)-2-METHYLPROPYLAMINE
|
|
C15H25NO2
|
|
(1R)-1-(4-BUTOXY-3-ETHOXYPHENYL)PENTYLAMINE
|
|
C17H29NO2
|
|
(1R)(4-BUTOXY-3-ETHOXYPHENYL)CYCLOPROPYLMETHYLAMINE
|
|
C16H25NO2
|
|
(R)-1-(4-BUTOXYPHENYL)ETHANAMINE
|
|
C12H19NO
|
|
(1R)-1-(3-BUTOXYPHENYL)ETHYLAMINE
|
|
C12H19NO
|
|
(1R)-1-(4-BUTOXYPHENYL)PROPYLAMINE
|
|
C13H21NO
|
|
(1R)-1-(4-BUTOXY-3-ETHOXYPHENYL)ETHYLAMINE
|
|
C14H23NO2
|
|
(1R)-1-(4-BUTOXY-3-ETHOXYPHENYL)PROPYLAMINE
|
|
C15H25NO2
|
|
(1R)-1-(4-BUTOXYPHENYL)-2-METHYLPROPYLAMINE
|
|
C14H23NO
|
|
(1R)(4-BUTOXYPHENYL)CYCLOPROPYLMETHYLAMINE
|
|
C14H21NO
|